Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Profit After Tax

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Profit After Tax History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit After Tax ₹1,883 Cr₹1,388 Cr₹715 Cr₹170 Cr₹442 Cr

What is the latest Profit After Tax of NATCO PHARMA ?

The latest Profit After Tax ratio of NATCO PHARMA is ₹1,883 Cr based on Mar2025 Consolidated results.
Year Profit After Tax
Mar2025₹1,883 Cr
Mar2024₹1,388 Cr
Mar2023₹715 Cr
Mar2022₹170 Cr
Mar2021₹442 Cr

How is Profit After Tax of NATCO PHARMA Trending?

Years Profit After Tax % Change
Mar2025 ₹1,883 Cr
35.66
Mar2024 ₹1,388 Cr
94.09
Mar2023 ₹715 Cr
320.76
Mar2022 ₹170 Cr
-61.57
Mar2021 ₹442 Cr -

Compare Profit After Tax of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,962.9 Cr 0.4% -6.9% -35.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,694.0 Cr -2.3% -7.3% -12.8% Stock Analytics
DIVIS LABORATORIES ₹160,721.0 Cr 0.8% -5.8% 4.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,016.0 Cr 0.8% 3.7% 20.8% Stock Analytics
CIPLA ₹106,946.0 Cr 0.7% -11.2% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,691.0 Cr -1.4% -3.8% -1.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

0.4%

-6.9%

-35.3%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses